A-770041 reverses paclitaxel and doxorubicin resistance in osteosarcoma cells

BACKGROUND: Reversing multidrug resistance (MDR) has been an important goal for clinical and investigational oncologists. In the last few decades, significant effort has been made to search for inhibitors to reverse MDR by targeting ATP-binding cassette (ABC) transporters (Pgp, MRP) directly, but th...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Duan, Zhenfeng, Zhang, Jianming, Ye, Shunan, Shen, Jacson, Choy, Edwin, Cote, Gregory, Harmon, David, Mankin, Henry, Hua, Yingqi, Zhang, Yu, Gray, Nathanael S, Hornicek, Francis J
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: BioMed Central 2014
Konular:
Research Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC4177239/
https://ncbi.nlm.nih.gov/pubmed/25236161
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2407-14-681
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller